May 18, 2024, 02:04
Elisa Agostinetto: At ESMO Breast24 Christine Desmedt presents an analysis of germline BRCA1/2 mutation
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared on X:
“At ESMO Breast24 Christine Desmedt presents an analysis of germline BRCA1/2 mutation and uncommon somatic alterations from patients enrolled in monarchE.
Consistent abemaciclib benefit for all mutations except somatic RB1 and BRCA2 Small sample size requires cautious interpretation!”
Source: Elisa Agostinetto/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 18, 2024, 22:22
Nov 18, 2024, 22:02
Nov 18, 2024, 21:55
Nov 18, 2024, 20:54
Nov 18, 2024, 18:36
Nov 18, 2024, 18:32